The Essential Thioredoxin Reductase of the Human Pathogenic Mold Aspergillus fumigatus Is a Promising Antifungal Target

Frontiers in Microbiology
Jasmin BinderSven Krappmann

Abstract

The identification of cellular targets for antifungal compounds is a cornerstone for the development of novel antimycotics, for which a significant need exists due to increasing numbers of susceptible patients, emerging pathogens, and evolving resistance. For the human pathogenic mold Aspergillus fumigatus, the causative agent of the opportunistic disease aspergillosis, only a limited number of established targets and corresponding drugs are available. Among several targets that were postulated from a variety of experimental approaches, the conserved thioredoxin reductase (TrxR) activity encoded by the trxR gene was assessed in this study. Its essentiality could be confirmed following a conditional TetOFF promoter replacement strategy. Relevance of the trxR gene product for oxidative stress resistance was revealed and, most importantly, its requirement for full virulence of A. fumigatus in two different models of infection resembling invasive aspergillosis. Our findings complement the idea of targeting the reductase component of the fungal thioredoxin system for antifungal therapy.

References

Jan 1, 1991·Methods in Enzymology·D HanahanF R Bloom
Jan 1, 1988·Archives of Microbiology·J D SchwennK Husmann
Mar 14, 1998·Molecular Biology of the Cell·Q WuJ R Aist
Sep 30, 2000·European Journal of Biochemistry·E S Arnér, A Holmgren
Dec 1, 2001·Free Radical Biology & Medicine·J Nordberg, E S Arnér
Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
May 23, 2003·Infection and Immunity·Sophie ParisJean-Paul Latgé
Feb 21, 2004·FEMS Microbiology Reviews·Kevin Kavanagh, Emer P Reeves
Feb 11, 2005·Eukaryotic Cell·Tricia A Missall, Jennifer K Lodge
Jul 16, 2005·Current Opinion in Microbiology·Fredj Tekaia, Jean-Paul Latgé
Aug 21, 2007·Current Opinion in Microbiology·Sarah M BrownJennifer K Lodge
Sep 13, 2008·PLoS Pathogens·Andrew McDonaghElaine Bignell
Jan 29, 2011·BMC Genomics·Ana Karina R AbadioMaria Sueli S Felipe
May 14, 2011·International Journal of Medical Microbiology : IJMM·Thomas HartmannSven Krappmann
Jun 19, 2012·The Journal of Clinical Investigation·Sixto M LealEric Pearlman
Dec 21, 2012·Science Translational Medicine·Gordon D BrownTheodore C White
Feb 27, 2014·Computational Biology and Chemistry·Yao LuLong Jason Lu
May 29, 2014·Molecular Biology Reports·Gajendra Kumar Azad, Raghuvir S Tomar
May 31, 2014·Current Protein & Peptide Science·Fulvio SaccocciaAndrea Bellelli
Feb 28, 2015·Biomolecules·Alessandra da Silva DantasJanet Quinn
Mar 31, 2015·Science·David W Denning, Michael J Bromley
Nov 12, 2015·Fungal Genetics and Biology : FG & B·Franziska WankaVera Meyer
Feb 28, 2016·The Journal of Microbiology·Neil A Brown, Gustavo H Goldman
Jun 4, 2016·Current Opinion in Microbiology·Sascha BrunkeBernhard Hube
Jul 6, 2016·Frontiers in Molecular Biosciences·Martin KaltdorfThomas Dandekar
Aug 27, 2016·Medical Mycology·Nir Osherov, Dimitrios P Kontoyiannis
Jan 16, 2019·Antimicrobial Agents and Chemotherapy·Andrew C MarshallJohn B Bruning
Nov 15, 2019·Clinical Microbiology Reviews·Jean-Paul Latgé, Georgios Chamilos
Dec 24, 2019·Frontiers in Microbiology·Ingo BauerHubertus Haas

❮ Previous
Next ❯

Citations

May 6, 2021·Genes·Jana Marie BoysenFalk Hillmann
Jul 13, 2021·Frontiers in Cellular and Infection Microbiology·Karina Mayumi SakitaErika Seki Kioshima

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
X-ray

Software Mentioned

GraphPad Prism
TetON
SDS
BLAST

Related Concepts

Related Feeds

Aspergillosis (ASM)

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Aspergillosis

Aspergillosis is the name given to a wide variety of diseases caused by infection by fungi of the genus Aspergillus. Aspergillosis occurs in chronic or acute forms which are clinically very distinct. Most cases of acute aspergillosis occur in patients with severely compromised immune systems. Chronic colonization or infection can cause complications in people with underlying respiratory illnesses. Discover the latest research on aspergillosis here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Antimicrobial Agents and Chemotherapy
Andrew C MarshallJohn B Bruning
Current Protein & Peptide Science
Fulvio SaccocciaAndrea Bellelli
© 2021 Meta ULC. All rights reserved